BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34881314)

  • 1. Statins and Peripheral Arterial Disease: A Narrative Review.
    Jansen-Chaparro S; López-Carmona MD; Cobos-Palacios L; Sanz-Cánovas J; Bernal-López MR; Gómez-Huelgas R
    Front Cardiovasc Med; 2021; 8():777016. PubMed ID: 34881314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and peripheral arterial disease.
    Markel A
    Int Angiol; 2015 Oct; 34(5):416-27. PubMed ID: 25410295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of peripheral arterial disease.
    Aronow WS
    Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral artery disease: therapeutic advances.
    Shamoun F; Sural N; Abela G
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):539-53. PubMed ID: 18402543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial disease in women.
    Aronow WS
    Maturitas; 2009 Dec; 64(4):204-11. PubMed ID: 19853389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM
    J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral arterial disease.
    Aronow WS
    Geriatrics; 2007 Jan; 62(1):19-25. PubMed ID: 17223718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?
    Poredos P; Jezovnik MK
    Int J Mol Sci; 2015 Jun; 16(7):14477-89. PubMed ID: 26121301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment.
    Firnhaber JM; Powell CS
    Am Fam Physician; 2019 Mar; 99(6):362-369. PubMed ID: 30874413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.
    Nastasi DR; Smith JR; Moxon JV; Trollope A; Golledge J
    Stroke; 2018 Dec; 49(12):2953-2960. PubMed ID: 30571405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
    Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rehabilitation Therapy in Peripheral Arterial Disease.
    Aggarwal S; Moore RD; Arena R; Marra B; McBride A; Lamb B; Martin BJ; Stone J
    Can J Cardiol; 2016 Oct; 32(10 Suppl 2):S374-S381. PubMed ID: 27692118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease.
    Shammas NW
    Vasc Health Risk Manag; 2007; 3(2):229-34. PubMed ID: 17580733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in Peripheral Arterial Disease.
    Chiesa ST; Papageorgiou N; Charakida M
    Curr Pharm Des; 2017 Sep; ():. PubMed ID: 28950823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of peripheral arterial disease of the lower extremities.
    Aronow WS
    Compr Ther; 2007; 33(4):247-56. PubMed ID: 18025617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral arterial disease: pathophysiology, risk factors, and role of antithrombotic therapy.
    Bradberry JC
    J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S37-44; quiz S44-5. PubMed ID: 15095934
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.